Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2023-03-31 Declaration of Voting R…
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM) for the company 'Corestemchemone'. It details the approval of financial statements, dividend resolutions, and the appointment of directors/auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides the official outcome of the shareholder votes held on 2023-03-31.
2023-03-31 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). This filing details the specific terms of the bond, the acquisition date, the reason for acquisition (early repayment), and the source of funds. Since this relates to the company's capital structure and debt management, it falls under the 'Capital/Financing Update' category.
2023-03-28 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). This filing details the specific financial transaction where the company repurchased its own convertible bonds. This falls under the category of capital structure changes and financing updates, specifically related to debt management. Given the specific nature of the filing (a mandatory disclosure of a corporate action regarding debt instruments), it is best classified as a Capital/Financing Update (CAP).
2023-03-27 Korean
사업보고서 (2022.12)
Annual Report Classification · 1% confidence The document is titled '사업보고서' (Business Report) for the 20th fiscal year (2022), covering the period from January 1, 2022, to December 31, 2022. It contains comprehensive sections including company overview, business details, financial statements, management discussion, and governance information. This structure corresponds to the standard Korean Annual Report (10-K equivalent). FY 2022
2023-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, revenue, profit/loss) for the current and previous fiscal years, and details regarding the auditor. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report, rather than the full, multi-page audit report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2022
2023-03-22 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Corestemchemon Co., Ltd. It includes the meeting date, location, agenda items (financial statements, director/auditor appointments, remuneration limits), and information regarding electronic voting and proxy solicitation. This document is a standard proxy statement/notice of meeting sent to shareholders to inform them of the upcoming AGM and request their participation/votes. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category.
2023-03-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.